bioRxivCancer BiologyPreprint
Single-cell Genomic Copy Number Evolution Reveals Frequent Loss of the Y chromosome in Esophageal Adenocarcinoma
Shiwei Yin, Na Zhong, Swati AgrawaliD, Bingru FengiD, Sneha Pradhan, Nathan K. Jobalia, Maryam Vaziripour, Sampath Poreddy, Laura A. KrestyiD, Erin Alexis GillaspieiD, Nicholas E. Dietz, Waddah B. Al‐RefaieiD, Kalyana C. NandipatiiD, Yusi FuiD, Jun XiaiD
- Citations
- 3
Abstract
The incidence of esophageal adenocarcinoma (EAC), an aggressive cancer, is rising in Western countries, and incidence is higher in men. To better understand the roles of DNA copy number evolution, tumor heterogeneity, and tumor microenvironment in EAC and its origins, we evaluated EAC, Barretts Esophagus (BE), and normal adjacent tissue using our previously developed ultra-sensitive, single-nucleus DNA copy number analysis (12,186 nuclei, 20 specimens) and single-nucleus RNA-sequencing (snRNA-seq; 87,027 nuclei, 32 specimens). Loss of Y (LOY) chromosome was rare in BE but markedly enriched in EAC. In genome unstable cells, complete LOY chromosome often coincided with X-chromosome duplication. We did not detect X-chromosome inactivation via XIST expression in cells with LOY, suggesting increased expression of X-chromosome genes and potential effects on tumor immune evasion. When considering patients clinical features, we identified distinct differences in tumor microenvironment by sex, age, and obesity status, particularly massively reduced immune cell composition in obese patients. Finally, our cell line models recapitulate LOY, and we identify the first candidate anti-LOY agent. Our findings highlight how LOY affects tumor subpopulations and shapes the tumor microenvironment during EAC progression.
- organism: human
- assay: scRNA-seq
- assay: DNA methylation
- research focus: cell type annotation
- research focus: differential expression
- research focus: trajectory inference
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Selective loss of Y chromosomes in lung adenocarcinoma modulates the tumor immune environment through cancer/testis antigens
Jonas Fischer, Katherine Hoff Shutta, … John F Quackenbush·bioRxiv·Sep 19, 2024
- Loss of the Y chromosome drives epigenetic and transcriptomic plasticity in lung adenocarcinoma
Kathleen Schlüter, Mei-Ju May Chen, … Maria Llamazares Prada·bioRxiv·Jun 5, 2026
- Loss of chromosome Y in primary tumors
M. Qi, J. Pang, … E. Rheinbay·bioRxiv·Aug 22, 2022
- Karyotype Evolution in Response to Chemoradiotherapy and Upon Recurrence of Esophageal Adenocarcinomas.
Karen van der Sluis, Johanna Wilhelmina van Sandick, … Liudmila L. Kodach·Cell ReportsPeer-reviewed·Nov 1, 2024
- Cell states and neighborhoods in distinct clinical stages of primary and metastatic esophageal adenocarcinoma
Josephine Yates, Camille A. Mathey-Andrews, … Eliezer M. Van Allen·Cell Reports MedicinePeer-reviewed·Jun 1, 2025
- Loss of the Y chromosome drives basal identity and metastatic potential via epigenetic reprogramming in pancreatic cancer
Madeleine Dorsch, Felix E.G. Beaudry, … Barbara M. Grüner·bioRxiv·Oct 8, 2026